trending Market Intelligence /marketintelligence/en/news-insights/trending/ba0r1nve-n1w-aqgvrqjyq2 content esgSubNav
In This List

Biostage closes $1M private placement

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Biostage closes $1M private placement

Biostage Inc. closed a private placement of 302,115 common shares to raise $1 million in gross proceeds.

The stocks were sold at $3.31 apiece to Jinhui Liu.

Holliston, Mass.-based Biostage is developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea.